Prognosi dell'epilessia in pazienti adolescenti e adulti di nuova diagnosi afferenti a due centri per l'epilessia: Probabilità di remissione e principali predittori prognostici

Translated title of the contribution: Prognosis of epilepsy in newly diagnosed adolescents and adults referred to two epilepsy centers. Probability of remission and risk factors

G. Boero, G. Bogliun, A. Del Felice, B. Frigeni, A. De Palo, G. De Agazio, N. Specchio, A. La Neve, M. Radaelli, E. Beghi, L. M. Specchio

Research output: Contribution to journalArticle

Abstract

About a third of patients diagnosed with epilepsy will not be fully controlled with antiepileptic drugs. The aim of this study is to assess, in a population of newly diagnosed patients treated with antiepileptic drugs, the rates of seizure remission in general and with reference to various prognostic factors. The study included patients with newly diagnosed epilepsy seen in two tertiary Italian centers (Monza and Bari). The cumulative probability of 2 year remission in the study population was calculated using Kaplan-Meier survival curves. Differences were tested with the Log-rank test. Multivariate analysis was performed with the Cox's proportional hazard function. The sample included 368 cases (men 185; women 183) aged 3 to 84 years (> 16 years 83%) followed for 25,815 months/person. 194 patients were enrolled in Monza and 174 in Bari. The cumulative probability of completing a 2 year remission period at 2 and 5 years was 42% and 56%, respectively. Remission rates were significantly higher in male (p = 0.043) and in patients with a family history of epilepsy (p=0.05). The results confirmed the good prognosis of epilepsy and above all of the genetic-determined ones.

Original languageItalian
Pages (from-to)39-42
Number of pages4
JournalBollettino - Lega Italiana contro l'Epilessia
Issue number121-122
Publication statusPublished - Jul 2003

Fingerprint

Epilepsy
Anticonvulsants
Kaplan-Meier Estimate
Population
Seizures
Multivariate Analysis

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Prognosi dell'epilessia in pazienti adolescenti e adulti di nuova diagnosi afferenti a due centri per l'epilessia : Probabilità di remissione e principali predittori prognostici. / Boero, G.; Bogliun, G.; Del Felice, A.; Frigeni, B.; De Palo, A.; De Agazio, G.; Specchio, N.; La Neve, A.; Radaelli, M.; Beghi, E.; Specchio, L. M.

In: Bollettino - Lega Italiana contro l'Epilessia, No. 121-122, 07.2003, p. 39-42.

Research output: Contribution to journalArticle

Boero, G. ; Bogliun, G. ; Del Felice, A. ; Frigeni, B. ; De Palo, A. ; De Agazio, G. ; Specchio, N. ; La Neve, A. ; Radaelli, M. ; Beghi, E. ; Specchio, L. M. / Prognosi dell'epilessia in pazienti adolescenti e adulti di nuova diagnosi afferenti a due centri per l'epilessia : Probabilità di remissione e principali predittori prognostici. In: Bollettino - Lega Italiana contro l'Epilessia. 2003 ; No. 121-122. pp. 39-42.
@article{d75abddae7d840e1a1f1e90ad500367c,
title = "Prognosi dell'epilessia in pazienti adolescenti e adulti di nuova diagnosi afferenti a due centri per l'epilessia: Probabilit{\`a} di remissione e principali predittori prognostici",
abstract = "About a third of patients diagnosed with epilepsy will not be fully controlled with antiepileptic drugs. The aim of this study is to assess, in a population of newly diagnosed patients treated with antiepileptic drugs, the rates of seizure remission in general and with reference to various prognostic factors. The study included patients with newly diagnosed epilepsy seen in two tertiary Italian centers (Monza and Bari). The cumulative probability of 2 year remission in the study population was calculated using Kaplan-Meier survival curves. Differences were tested with the Log-rank test. Multivariate analysis was performed with the Cox's proportional hazard function. The sample included 368 cases (men 185; women 183) aged 3 to 84 years (> 16 years 83{\%}) followed for 25,815 months/person. 194 patients were enrolled in Monza and 174 in Bari. The cumulative probability of completing a 2 year remission period at 2 and 5 years was 42{\%} and 56{\%}, respectively. Remission rates were significantly higher in male (p = 0.043) and in patients with a family history of epilepsy (p=0.05). The results confirmed the good prognosis of epilepsy and above all of the genetic-determined ones.",
keywords = "Epilepsy, Prognosis, Risk factors",
author = "G. Boero and G. Bogliun and {Del Felice}, A. and B. Frigeni and {De Palo}, A. and {De Agazio}, G. and N. Specchio and {La Neve}, A. and M. Radaelli and E. Beghi and Specchio, {L. M.}",
year = "2003",
month = "7",
language = "Italian",
pages = "39--42",
journal = "Bollettino - Lega Italiana contro l'Epilessia",
issn = "0394-560X",
publisher = "Lega Italiana contro l'Epilessia",
number = "121-122",

}

TY - JOUR

T1 - Prognosi dell'epilessia in pazienti adolescenti e adulti di nuova diagnosi afferenti a due centri per l'epilessia

T2 - Probabilità di remissione e principali predittori prognostici

AU - Boero, G.

AU - Bogliun, G.

AU - Del Felice, A.

AU - Frigeni, B.

AU - De Palo, A.

AU - De Agazio, G.

AU - Specchio, N.

AU - La Neve, A.

AU - Radaelli, M.

AU - Beghi, E.

AU - Specchio, L. M.

PY - 2003/7

Y1 - 2003/7

N2 - About a third of patients diagnosed with epilepsy will not be fully controlled with antiepileptic drugs. The aim of this study is to assess, in a population of newly diagnosed patients treated with antiepileptic drugs, the rates of seizure remission in general and with reference to various prognostic factors. The study included patients with newly diagnosed epilepsy seen in two tertiary Italian centers (Monza and Bari). The cumulative probability of 2 year remission in the study population was calculated using Kaplan-Meier survival curves. Differences were tested with the Log-rank test. Multivariate analysis was performed with the Cox's proportional hazard function. The sample included 368 cases (men 185; women 183) aged 3 to 84 years (> 16 years 83%) followed for 25,815 months/person. 194 patients were enrolled in Monza and 174 in Bari. The cumulative probability of completing a 2 year remission period at 2 and 5 years was 42% and 56%, respectively. Remission rates were significantly higher in male (p = 0.043) and in patients with a family history of epilepsy (p=0.05). The results confirmed the good prognosis of epilepsy and above all of the genetic-determined ones.

AB - About a third of patients diagnosed with epilepsy will not be fully controlled with antiepileptic drugs. The aim of this study is to assess, in a population of newly diagnosed patients treated with antiepileptic drugs, the rates of seizure remission in general and with reference to various prognostic factors. The study included patients with newly diagnosed epilepsy seen in two tertiary Italian centers (Monza and Bari). The cumulative probability of 2 year remission in the study population was calculated using Kaplan-Meier survival curves. Differences were tested with the Log-rank test. Multivariate analysis was performed with the Cox's proportional hazard function. The sample included 368 cases (men 185; women 183) aged 3 to 84 years (> 16 years 83%) followed for 25,815 months/person. 194 patients were enrolled in Monza and 174 in Bari. The cumulative probability of completing a 2 year remission period at 2 and 5 years was 42% and 56%, respectively. Remission rates were significantly higher in male (p = 0.043) and in patients with a family history of epilepsy (p=0.05). The results confirmed the good prognosis of epilepsy and above all of the genetic-determined ones.

KW - Epilepsy

KW - Prognosis

KW - Risk factors

UR - http://www.scopus.com/inward/record.url?scp=10744221628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10744221628&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:10744221628

SP - 39

EP - 42

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

SN - 0394-560X

IS - 121-122

ER -